Kameel D. Farag - 05 Jan 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Reporting relationship: Director
Issuer ticker: BIVI
Reported as of: 05 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jan 2026, 17:01:17 UTC
Prior SEC filing: 18 Dec 2025
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Joanne Wendy Kim, attorney-in-fact for Kameel Farag

Key filing fact

Kameel D. Farag filed Form 4 for BIOVIE INC. (BIVI) on 09 Jan 2026.

Key facts

This page summarizes Kameel D. Farag's Form 4 filing for BIOVIE INC. (BIVI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jan 2026, 17:01.

Change

Previous filing in this sequence was filed on 18 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002093620 Primary reporting owner

Farag Kameel D.

Relationship: Director
Address: C/O BIOVIE INC., 680 W NYE LANE STE. 201, CARSON CITY
Signature: /s/ Joanne Wendy Kim, attorney-in-fact for Kameel Farag
Signature date: 09 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIVI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +57,500
Change %
Price: $0.000000
Shares after: 57,500
Date: 05 Jan 2026
Ownership: Direct
Underlying class: COMMON STOCK
Underlying amount: 57,500
Exercise price: $1.31
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.